These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1492007)

  • 1. Evaluation and comparison of the adverse effects of streptokinase and alteplase.
    Tisdale JE; Colucci RD; Ujhelyi MR; Kluger J; Fieldman A; Chow MS
    Pharmacotherapy; 1992; 12(6):440-4. PubMed ID: 1492007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Coronary flow and hemorrhagic complications after alteplase and streptokinase administration in patients with acute myocardial infarction].
    Kostić T; Perisić Z; Milić D; Apostolović S; Martinović SS; Bozinović N; Mitov V; Vidanović M
    Vojnosanit Pregl; 2009 Mar; 66(3):218-22. PubMed ID: 19341228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of alteplase for myocardial infarction in two community hospitals.
    Krichbaum DW; Grabavoy G; Finley RC; Hamid I
    Am J Hosp Pharm; 1990 Jul; 47(7):1535-40. PubMed ID: 2114788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor antagonism and streptokinase-induced hypotension in clinical acute myocardial infarction.
    Taylor R; Fatovich D; Hitchcock T; Morrison C; Curtis L
    Clin Sci (Lond); 2001 Jun; 100(6):601-7. PubMed ID: 11352774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombolytic therapy in acute myocardial infarct and pulmonary artery thromboembolism].
    Iakovlev VB; Gospodarenko AL; Makarenko AS
    Voen Med Zh; 1993 Jun; (6):45-7. PubMed ID: 8367952
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacoepidemiology of bleeding events after use of r-alteplase or streptokinase in acute myocardial infarction.
    McLeod DC; Coln WG; Thayer CF; Perfetto EM; Hartzema AG
    Ann Pharmacother; 1993; 27(7-8):956-62. PubMed ID: 8364282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic treatment in acute myocardial infarction.
    Verstraete M
    Circulation; 1990 Sep; 82(3 Suppl):II96-109. PubMed ID: 2118432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated streptokinase--a new thrombolytic regimen in acute myocardial infarction.
    Tatu-Chiţoiu G; Teodorescu C; Flueraşu A; Căpraru P; Guran M; Dan M; Chioncel V; Bumbu A; Cornaciu S
    Rom J Intern Med; 1998; 36(3-4):183-96. PubMed ID: 10822515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of helicopter transport and out-of-hospital intravenous fibrinolytic therapy in patients with evolving myocardial infarction.
    Topol EJ; Fung AY; Kline E; Kaplan L; Landis D; Strozeski M; Burney RE; Pitt B; O'Neill WW
    Cathet Cardiovasc Diagn; 1986; 12(3):151-5. PubMed ID: 3089627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary artery thrombolysis: comparison of approved agents.
    Porter RS; DiPalma JR
    Am Fam Physician; 1991 Aug; 44(2):591-8. PubMed ID: 1907085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic therapy in acute coronary thrombosis.
    Ramalanjaona GR; Mathew JC
    Indiana Med; 1990 Jun; 83(6):410-2. PubMed ID: 2112180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients.
    Grijseels EW; Bouten MJ; Lenderink T; Deckers JW; Hoes AW; Hartman JA; van der Does E; Simoons ML
    Eur Heart J; 1995 Dec; 16(12):1833-8. PubMed ID: 8682015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombolytic therapy for myocardial infarction in oral anticoagulation].
    Pizzulli L; Lüderitz B
    Dtsch Med Wochenschr; 1996 Mar; 121(13):424. PubMed ID: 8681737
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemorrhagic ocular complications associated with the use of systemic thrombolytic agents.
    Chorich LJ; Derick RJ; Chambers RB; Cahill KV; Quartetti EJ; Fry JA; Bush CA
    Ophthalmology; 1998 Mar; 105(3):428-31. PubMed ID: 9499772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
    Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombolytic therapy in acute myocardial infarct].
    Verstraete M
    Recenti Prog Med; 1990 Apr; 81(4):287-98. PubMed ID: 2198644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
    De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG
    Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks versus benefits: the alteplase experience.
    Green JA
    Am J Hosp Pharm; 1989 Nov; 46(11 Suppl 2):S15-9. PubMed ID: 2513714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.